// App-Quantinova.ai

802 : Fondaparinux Vs Low Molecular Weight Heparin in the Treatment of Non‐Malignant Portal Vein Thrombosis in Patients with Cirrhosis

Researchers

Presenter

  • Salvatore Piano

Principal Investigators

  • Alberto Zanetto

  • Marta Tonon

  • David Sacerdoti

  • Silvia Tonello

  • Paolo Simioni

  • Giancarlo Bombonato

  • Patrizia Burra

  • Marco Senzolo

  • Paolo Angeli

Medical Centers

  • Department of Medicine, University of Toronto

  • Gastroenterology and Multivisceral Transplant Unit, University of Padova,

  • Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University Hospital of Padua,

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Venous thrombosis

  • Cirrhosis

Biomarkers

  • N/A

Drug/Treatment

  • Fondaparinux sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved